Lucrin Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms. International, Multicenter Post-marketing Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2012
At a glance
- Drugs Leuprorelin; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms LEMON
- Sponsors Abbott Laboratories
- 14 Feb 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 14 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2010 New trial record